Research

What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.

360 Articles

Research
April 5, 2021 • 2 Min

Adaptive Pre-Surgery Therapy for Patients with Localized Pancreatic Cancer

Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?

computer rendering of KRAS protein structure
Research
March 10, 2021 • 3 Min

A New Vaccine for Advanced Pancreatic Cancer

An mRNA vaccine that works against KRAS mutations is being tested with and without immunotherapy for advanced or metastatic pancreatic cancer.

Cancer cells in green and blue
Research
February 25, 2021 • 2 Min

Adding Focused Radiation to Standard Pancreatic Cancer Treatment

Researchers are using IORT–intraoperative radiation therapy–to treat pancreatic cancer that cannot be surgically removed.

Kenneth Yu, MD
Research
February 22, 2021 • 5 Min

Blood-Based Test Predicts What Drugs May Work Best

Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.

Dr. Andrea Califano
Research
February 9, 2021 • 4 Min

RNA Precision Trial for Pancreatic Cancer Opens At Columbia

Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.

Tumor Board Tuesday logo and Twitter icon
Research
February 1, 2021 • 4 Min

Tweeting About Tumors and How Best to Provide Care

Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.

Dr. Conan Kinsey
Research
January 27, 2021 • 6 Min

A Look at MEK and Autophagy Inhibition

Dr. Conan Kinsey looks at the MEK pathway as way to make immunotherapy more effective for pancreatic cancer patients.

Noelle LoConte, MD
Research
January 13, 2021 • 5 Min

Finding More Targets for Pancreatic Cancer Treatment

Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.

DNA scan of rainbow colors on a royal blue background
Research
January 5, 2021 • 1 Min

Comparing Effectiveness of Chemotherapy Before and After Surgery

Is chemotherapy before and after pancreatic cancer surgery more effective than just chemotherapy after surgery?

Green and red microscope
Research
December 30, 2020 • 6 Min

A Year in Review: 2020

In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]

Dr. Teresa Zimmers
Research
December 16, 2020 • 6 Min

Cachexia Research Gaining Momentum

Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.

Dark leafy greens in a bowl
Research
December 8, 2020 • 1 Min

Medical Diet Study for Pancreatic Cancer Patients

Researchers are looking at the role of one particular nutrient in a diet study for pancreatic cancer patients.

Dr. Michael Rosenthal
Research
December 3, 2020 • 7 Min

Artificial Intelligence and Early Detection of Pancreatic Cancer

How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.

Dr. Vincent Picozzi
Research
November 11, 2020 • 5 Min

Multi-Site Precision Promise Study Opens

Dr. Vincent Picozzi explains how Precision Promise clinical trial will use a personalized approach for pancreatic cancer patients.

colored lights in 1/4 of a circle
Research
November 6, 2020 • 2 Min

An Expanded Access Trial for Cancer Patients with Specific Mutations

An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.